CTSD — Cathepsin D
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CTSD — Cathepsin D</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CTSD</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin D</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CPSD, CLN10</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p15.5</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1509" target="_blank">1509</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811" target="_blank">ENSG00000103811</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P07339" target="_blank">P07339</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, liver, macrophages, neurons, microglia</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style
...
CTSD — Cathepsin D
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CTSD — Cathepsin D</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CTSD</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cathepsin D</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>CPSD, CLN10</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p15.5</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/1509" target="_blank">1509</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811" target="_blank">ENSG00000103811</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/P07339" target="_blank">P07339</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, liver, macrophages, neurons, microglia</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/adh" style="color:#ef9a9a">ADH</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">848 edges</a></td>
</tr>
</table>
CTSD — Cathepsin D
Overview
Cathepsin D is a lysosomal aspartic protease encoded by the CTSD gene. It is one of the major lysosomal proteases responsible for protein degradation, cellular turnover, and autophagy. CTSD plays a dual role in neurodegeneration — it can promote cell death through apoptotic mechanisms, but also serves as a critical component of the autophagy-lysosome pathway that clears [alpha-synuclein](/genes/snca) and amyloid-beta[@liu2020]. CTSD dysfunction has been implicated in both [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease).
Gene and Protein Structure
CTSD is located on chromosome 11p15.5 and encodes a 412-amino acid protein. The mature enzyme is generated through a multi-step process:
- Pre-proenzyme: Signal peptide + prosegment + mature enzyme
- Procathepsin D (48 kDa): Secreted/lysosomal form with prosegment
- Mature cathepsin D (34 kDa): Activated protease consisting of light and heavy chains
The active site contains two aspartic acid residues that coordinate a water molecule for peptide bond hydrolysis.
Normal Function
Lysosomal Protein Degradation
Cathepsin D is essential for lysosomal proteolysis:
- Bulk protein turnover: Degrades long-lived proteins in lysosomes
- Autophagy substrate clearance: Processes material delivered via autophagosomes
- Precursor processing: Activates other enzymes and processes hormones and growth factors
Autophagy-Lysosome Pathway
CTSD functions as a key executioner in the autophagy pathway:
Autophagosome-lysosome fusion: CTSD activity required for this step
Aggregate clearance: Degrades protein aggregates including alpha-synuclein
Organelle turnover: Breaks down mitochondria (mitophagy) and other organellesCellular Homeostasis
- Cell survival regulation: Modulates apoptosis through Bcl-2 family interactions
- Growth factor processing: Generates bioactive peptides from precursors
- Immune function: Processes antigens for MHC presentation
Role in Neurodegenerative Disease
Alzheimer's Disease
In Alzheimer's disease, CTSD has complex and potentially dual roles:
Amyloid-beta metabolism: CTSD can both generate and degrade amyloid-beta:
- Cleaves [APP](/genes/app) to produce amyloid-beta fragments
- Degrades extracellular amyloid-beta plaques
- Dysregulation contributes to amyloid accumulation
Neuronal vulnerability: CTSD deficiency leads to:
- Lysosomal storage abnormalities
- Accumulation of lipofuscin (age pigment)
- Impaired neuronal survival[@wu2023]
Parkinson's Disease
CTSD deficiency causes lysosomal dysfunction that drives [alpha-synuclein](/genes/snca) aggregation[@liu2020]:
- Loss of CTSD impairs autophagosome-lysosome fusion
- Alpha-synuclein accumulates in toxic oligomeric forms
- Dopaminergic neurons are particularly vulnerable
- Mouse models show PD-like motor phenotypes
Multiple System Atrophy
CTSD dysregulation contributes to multiple system atrophy pathology[@tan2021]:
- Glial cytoplasmic inclusions contain alpha-synuclein
- CTSD activity is altered in affected brain regions
- Neuroinflammation is modulated by CTSD status
Mechanistic Pathways
Mermaid diagram (expand to render)
Therapeutic Strategies
CTSD Modulation
Increasing CTSD activity represents a therapeutic approach for neurodegenerative disease:
- Small molecule activators: Enhance CTSD maturation and activity
- Gene therapy: AAV-mediated CTSD expression
- Protein replacement: Exogenous CTSD delivery
Autophagy Enhancement
Since CTSD is central to autophagy-lysosome function:
- mTOR inhibitors (rapamycin, everolimus) induce autophagy upstream
- Combined approach: increase flux (upstream) plus enhance clearance (CTSD)
Relationship to GBA1
CTSD and [GBA1](/genes/gba1) converge on the lysosomal pathway:
- GBA1 deficiency impairs glycolipid degradation and affects CTSD maturation
- Both deficiencies lead to alpha-synuclein accumulation
- Combined targeting may be more effective than single approach
Research Directions
Key questions in CTSD biology and therapy:
How does CTSD deficiency specifically affect dopaminergic neurons?
Can pharmacological CTSD activation provide neuroprotection in vivo?
What is the relationship between CTSD and other lysosomal genes (GBA1, LRRK2)?
Are CTSD promoter variants associated with disease progression?See Also
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Alpha-Synuclein](/genes/snca)
- [GBA1 Gene](/genes/gba1)
- [LRRK2 Gene](/genes/lrrk2)
- [Autophagy Pathway](/mechanisms/autophagy-pathway)
- [Lysosomal Dysfunction](/mechanisms/lysosome-dysfunction)
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/1509](https://www.ncbi.nlm.nih.gov/gene/1509)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000103811)
- UniProt: [https://www.uniprot.org/uniprot/P07339](https://www.uniprot.org/uniprot/P07339)
- OMIM: [https://omim.org/entry/116840](https://omim.org/entry/116840)
Pathway Diagram
The following diagram shows the key molecular relationships involving CTSD — Cathepsin D discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)